FA
SURF

Forefront Analytics’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Forefront Analytics’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-61,156
Closed -$42.7K – 79
2023
Q1 		$42.7K Sell
61,156
-2,200
-3% -$1.78K 0.02% 76
2022
Q4 		$52K Sell
63,356
-3,482
-5% -$3.43K 0.03% 69
2022
Q3 		$70K Buy
66,838
+25,150
+60% +$40.2K 0.04% 58
2022
Q2 		$71K Buy
41,688
+21,975
+111% +$45.6K 0.03% 56
2022
Q1 		$62K Buy
+19,713
New +$69.1K 0.02% 67

Other funds holding SURF

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Forefront Analytics's SURF Position: Q2 2023 in Review

Forefront Analytics sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2023, closing a stake of 61,156 shares — an estimated $42.7K sold.

Forefront Analytics first reported a position in SURF in Q1 2022 and held it in 5 quarters. The position peaked at $71K in Q2 2022. 61 funds tracked by Wall St. Rank hold SURF as of Q2 2023.

  • Forefront Analytics reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Forefront Analytics sold 61,156 Surface Oncology, Inc. Common Stock shares in Q2 2023, an estimated $42.7K.
  • Forefront Analytics first reported a position in Surface Oncology, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Forefront Analytics's Surface Oncology, Inc. Common Stock position peaked at $71K in Q2 2022.
  • 61 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2023.

Based on Forefront Analytics's 13F filing for Q2 2023, filed 11 Aug 2023.